DNA
$1.23
Ginkgo Bioworks Hldgs
$.01
.82%
DNA
Earnings Whisper ®
N/A
1st Quarter March 2023
Consensus:  ($0.09)
Revenue:  $73.74 Mil
Wednesday
May 31
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when DNA reports earnings?
Beat
Meet
Miss

Where is DNA's stock price going from here?
Up
Flat
Down
Stock chart of DNA
Analysts
Summary of analysts' recommendations for DNA
Score
Grade
Pivots
Resistance
$1.45
$1.39
$1.31

$1.25

Support
$1.17
$1.11
$1.03
Tweet
Growth
Description
Genentech, Inc. is a biotechnology company that uses human genetic information to discover, develop, manufacture and market human pharmaceuticals for significant unmet medical needs. As part of the company's program of research and development, a number of products are in various stages of development. Product development efforts cover a wide range of disorders or medical conditions, including cancer, respiratory disorders, cardiovascular diseases, endocrine disorders, inflammatory and immune problems, and neurological disorders.